Crossmark

Markers of cardiovascular risk and their reversibility with acute oxygen therapy in Kyrgyz highlanders with high altitude pulmonary hypertension

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2021.02.001

Published Online: 2025-03-10

Published Print: 2021-09-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Furian, M. https://orcid.org/0000-0002-8518-5029
Latshang, T.D.

Aeschbacher, S.S. https://orcid.org/0000-0003-2815-1639
Sheraliev, U.

Marazhapov, N.H.

Mirrakhimov, E. https://orcid.org/0000-0003-2982-6108
Ulrich, S.

Sooronbaev, T.M.

Bloch, K.E.
Funding

Funding for this research was provided by:

Lungenliga Zurich

OPO Foundation
License Information

Version of Record valid from 2021-09-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2020-10-14

Accepted: 2021-02-03

Published: 2025-03-10